drugset / Trial / NCT02498509

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

NCT02498509

Phase 3 Completed 459 enrolled Chong Kun Dang Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

Clinical Trial to Evaluate the Efficacy and Safety of CKD-342

Timeline

Start
2015-05
Primary completion
2016-03
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-342 Unknown
Comparator Levocabastine Small molecule
Comparator Mometasone furoate Other / unclassified